Innervation of lymphoid organs: Clinical implications

Clinical Neuroscience Research

Volumn 6, Issue 1-2, 2006, Pages 3-33

  Bellinger, Denise L ^a   Millar, Brooke A ^a   Perez, Sam ^a   Carter, Jeff ^a   Wood, Carlo ^a   ThyagaRajan, Srinivasan ^a   Molinaro, Christine ^a   Lubahn, Cheri ^b   Lorton, Dianne ^b  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Autonomic; Immune modulation; Lymphoid organs; Noradrenergic; Sympathetic innervation

Indexed keywords

ADRENERGIC RECEPTOR; NORADRENALIN;

ADRENERGIC SYSTEM; ARTICLE; BONE MARROW; BONE MARROW CELL; BRAIN FUNCTION; CELL ACTIVITY; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CELL TRANSPORT; CIRCULATION; CYTOKINE PRODUCTION; HEMATOPOIESIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOREGULATION; INNERVATION; LYMPHOCYTE; LYMPHOID CELL; LYMPHOID ORGAN; LYMPHOID TISSUE; MEDICAL RESEARCH; MUCOSA; NERVE ENDING; NERVE STIMULATION; NEUROIMMUNOLOGY; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE; THYMUS FUNCTION;

EID: 33746713650     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnr.2006.04.003     Document Type: Article

References (452)

1. Bjurholm A., Kreicbergs A., Terenius L., Goldstein M., and Schultzberg M. Neuropeptide Y-, tyrosine hydroxylase- and vasoactive intestinal polypeptide-immunoreactive nerve in bone and surrounding tissues. J Autonom Nerv Syst 25 (1988) 119-125
2. Tabarowski Z., Gibson-Berry K., and Felten S.Y. Noradrenergic and peptidergic innervation of the mouse femur bone marrow. Acta Histochem 98 (1996) 453-457
3. Felten D.L., Gibson-Berry K., and Wu J.H. Innervation of bone marrow by tyrosine hydroxylase-immunoreactive nerve fibers and hemopoiesis-modulating activity of a β-adrenergic agonist in mouse. Mol Biol Hematopoiesis 5 (1996) 627-636
4. Felten D.L., Felten S.Y., Carlson S.L., Olschowka J.A., and Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol 135 (1985) 755s-765s
5. Bellinger D.L., Felten S.Y., Ackerman K.D., Lorton D., Madden K.S., and Felten D.L. Noradrenergic sympathetic innervation of lymphoid organs during development, aging, and in immune disease. In: Amenta F. (Ed). Aging of the autonomic nervous system (1992), CRC Press, Boca Raton 243-284
6. Felten S.Y., and Felten D.L. The innervation of lymphoid tissue. In: Ader R., Felten D.L., and Cohen N. (Eds). Psychoneuroimmunology. 2nd ed. (1991), Academic Press, New York 27-69
7. Bellinger D.L., Lorton D., Lubahn C., and Felten D.L. Innervation of lymphoid organs-association of nerves with cells of the immune system and their implications in disease. In: Ader R., Felten D.L., and Cohen N. (Eds). Psychoneuroimmunology. 3rd ed (2001), Academic Press, New York 55-111
8. Yamazaki K., and Allen T.D. Ultrastructural morphometric study of efferent nerve terminals on murine bone marrow stromal cells, and the recognition of a novel anatomical unit: the 'neuro-reticular complex'. Am J Anat 187 (1990) 261-276
9. Afan A.M., Broome C.S., Nicholls S.E., Whetton A.D., and Miyan J.A. Bone marrow innervation regulates cellular retention in the murine haemopoietic system. Br J Haematol 98 (1997) 569-577
10. Garcia J.F., and van Dyke D.C. Response of rats of various ages to erythropoietin. Proc Soc Exp Biol Med 106 (1961) 585-588
11. Maestroni G.J., Cosentino M., Marino F., et al. Neural and endogenous catecholamines in the bone marrow. Circadian association of norepinephrine with hematopoiesis?. Exp Hematol 26 (1998) 1172-1177
12. Marino F., Cosentino M., Bombelli R., et al. Measurement of catecholamines in mouse bone marrow by means of HPLC with electrochemical detection. Haematologica 82 (1997) 392-394
13. Besedovsky H.O., del Rey A.E., Sorkin E., Da Prada M., and Keller H.H. Immunoregulation mediated by the sympathetic nervous system. Cell Immunol 48 (1979) 346-355
14. Madden K.S., Sanders V.M., and Felten D.L. Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu Rev Pharmacol Toxicol 35 (1995) 417-448
15. Tang Y., Shankar R., Gamelli R., and Jones S. Dynamic norepinephrine alterations in bone marrow: evidence of functional innervation. J Neuroimmunol 96 (1999) 182-189
16. Maestroni G.J., and Conti A. Modulation of hematopoiesis via alpha 1-adrenergic receptors on bone marrow cells. Exp Hematol 22 (1994) 313-320
17. Lipski S. Effects of beta-adrenergic stimulation on bone-marrow function in normal and sublethally irradiated mice. I. The effect of isoproterenol on cAMP content in bone-marrow cells in vivo and in vitro. Int J Radiat Biol Relat Stud Phys Chem Med 29 (1976) 359-366
18. Lipski S. Effect of beta-adrenergic stimulation by isoproterenol on proliferation and differentiation of mouse bone marrow cells in vivo. Pol J Pharmacol Pharm 32 (1980) 281-287
19. Beckman B., Mirand E., and Fisher J.W. Effects of beta adrenergic agents and prostaglandin E1 on erythroid colony (CFU-E) growth and cyclic AMP formation in Friend erythroleukemic cells. J Cell Physiol 105 (1980) 355-361
20. Byron J.W. Evidence for a beta-adrenergic receptor initiating DNA synthesis in haemopoietic stem cells. Exp Cell Res 71 (1972) 228-232
21. Byron J.W., and Fox M. Adrenergic receptor blocking agents modifying the radioprotective action of T.A.B. Br J Radiol 42 (1969) 400 [1]
22. Dresch C., Minc J., Poirier O., and Bouvet D. Effect of beta adrenergic agonists on beta blocking agents on hemopoiesis in human bone marrow. Biomedicine 34 (1981) 93-98
23. Sudo N., Yu X.N., Sogawa H., and Kubo C. Restraint stress causes tissue-specific changes in the immune cell distribution. Neuroimmunomodulation 4 (1997) 113-119
24. Maestroni G.J. Adrenergic regulation of haematopoiesis. Pharmacol Res 32 (1995) 249-253
25. Maestroni G.J., Conti A., and Pedrinis E. Effect of adrenergic agents on hematopoiesis after syngenic bone marrow transplantation in mice. Blood 80 (1992) 1178-1182
26. Maestroni G.J., and Conti A. Noradrenergic modulation of lymphohematopoiesis. Int J Immunopharmacol 16 (1994) 117-122
27. Benestad H.B., Strom-Gundersen I., Iversen P.O., Haug E., and Nja A. No neuronal regulation of murine bone marrow function. Blood 91 (1998) 1280-1287
28. Tran M.A., Dang Tran L., Lafontan M., and Montastruc P. Adrenergic neurohumoral influences on FFA release from bone marrow adipose tissue. J Pharmacol 16 (1985) 171-179
29. Besedovsky H.O., del Rey A.E., Sorkin E., et al. lymphocytes affect the development of sympathetic innervation of mouse spleen. Brain Behav Immun 1 (1987) 185-193
30. Bulloch K., and Pomerantz W. Autonomic nervous system innervation of thymic-related lymphoid tissue in wild type and nude mice. J Comp Neurol 228 (1984) 57-68
31. Bellinger D.L., Felten S.Y., and Felten D.L. Maintenance of noradrenergic sympathetic innervation of the involuted thymus of the aged Fischer 344 rats. Brain Behav Immun 2 (1988) 133-150
32. Felten D.L., and Felten S.Y. Innervation of the thymus. In: Kendal M.D., and Ritter M.A. (Eds). Thymus update (1989), Harwood Academic Publishers, London 73-88
33. Ackerman K.D., Bellinger D.L., Felten S.Y., and Felten D.L. Ontogeny and senescence of noradrenergic innervation of the rodent thymus and spleen. In: Ader R., Felten D.L., and Cohen N. (Eds). Psychoneuroimmunology. 2nd ed (1991), Academic Press, New York 71-125
34. Kurz B., Feindt J., Von Gaudecker B., Kranz A., Loppnow H., and Mentlein R. Beta-adrenoceptor-mediated effects in rat cultured thymic epithelial cells. Br J Pharmacol 120 (1997) 1041-1408
35. Kendall M.D., and Al-Shawaf A.A. Innervation of the rat thymus gland. Brain Behav Immun 5 (1991) 9-28
36. Vizi E.S., Orso E., Osipenko O.N., Hasko G., and Elenkov I.J. Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes. Neuroscience 68 (1995) 1263-1276
37. de Leeuw F.E., Jansen G.H., Batanero E., van Wichen D.F., Huber J., and Schuurman H.J. The neural and neuroendocrine component of the human thymus. I. Nerve-like structures. Brain Behav Immun 6 (1992) 234-248
38. Kranz A., Kendall M.D., and Von Gaudecker B. Studies on rat and human thymus to demonstrate immunoreactivity of calcitonin gene-related peptide, tyrosine hydroxylase and neuropeptide Y. J Anat 191 (1997) 441-450
39. Nance D.M., Hopkins D.A., and Bieger D. Re-investigation of the innervation of the thymus gland in mice and rats. Brain Behav Immun 1 (1987) 134-147
40. Tollefson L., and Bulloch K. Dual-label retrograde transport: CNS innervation of the mouse thymus distinct from other mediastinum viscera. J Neurosci Res 25 (1990) 20-28
41. Marchetti B., Morale M.C., Paradis P., and Bouvier M. Characterization, expression, and hormonal control of a thymic beta-2-adrenergic receptor. Am J Physiol 267 (1994) E718-E731
42. Leposavic G., Micic M., Ugresic N., Bogojevic M., and Isakovic K. Components of sympathetic innervation of the rat thymus during late foetal and postnatal development: histofluorescence and biochemical study. Sympathetic innervation of the rat thymus. Thymus 19 (1992) 77-87
43. Williams J.M., and Felten D.L. Sympathetic innervation of murine thymus and spleen: a comparative study. Anat Rec 199 (1981) 531-542
44. Al-Shawaf A.A., Kendall M.D., and Cowen T. Identification of neural profiles containing vasoactive intestinal polypeptide, acetylcholinesterase and catecholamines in the rat thymus. J Anat 174 (1991) 131-143
45. Cavallotti C., Artico N., and Cavallotti D. Occurrence of adrenergic nerve fibers and noradrenaline in thymus gland of juvenile and aged rats. Immunol Lett 70 (1999) 53-62
46. Müller S., and Weihe E. Interrelation of peptidergic innervation with mast cells and ED1-positive cells in rat thymus. Brain Behav Immun 5 (1991) 55-72
47. Brouxhon S.M., Prasad A.V., Joseph S.A., Felten D.L., and Bellinger D.L. Localization of corticotropin-releasing factor in primary and secondary lymphoid organs of the rat. Brain Behav Immun 12 (1998) 107-122
48. Elenkov I.J., and Vizi E.S. Presynaptic modulation of release of noradrenaline from the sympathetic nerve terminals in the rat spleen. Neuropharmacology 30 (1991) 1319-1324
49. Hasko G., Elenkov I.J., and Vizi E.S. Presynaptic receptors involved in the modulation of release of noradrenaline from the sympathetic nerve terminals of the rat thymus. Immunol Lett 47 (1995) 133-137
50. Docherty J.R. Subtypes of functional alpha1- and alpha2-adrenoceptors. Eur J Pharmacol 361 (1998) 1-15
51. Wonnacott S. Presynaptic nicotinic Ach receptors. Trends Neurosci 20 (1998) 92-98
52. Vizi E.S., and Lendvai B. Modulatory role of presynaptic nicotinic receptors in synaptic and nonsynaptic chemical communication in the central nervous system. Brain Res Brain Res Rev 30 (1999) 219-235
53. Madden K.S. Catecholamines, sympathetic nerves, and immunity. In: Ader R., Cohen N., and Felten D.L. (Eds). Psychoneuroimmunology. 3rd ed (2001), Academic Press, New York 197-216
54. Fuchs B.A., Albright J.W., and Albright J.F. Beta-adrenergic receptors on murine lymphocytes: density varies with cell maturity and lymphocyte subtype and is decreased after antigen administration. Cell Immunol 114 (1988) 231-245
55. Radojcic T., Baird S., Darko D., Smith D., and Bulloch K. Changes in beta-adrenergic receptor distribution on immunocytes during differentiation: an analysis of T cells and macrophages. J Neurosci Res 30 (1991) 328-335
56. Morale M.C., Gallo F., Batticane N., and Marchetti B. The immune response evokes up-and downmodulation of beta 2-adrenergic receptor messenger RNA concentration in the male rat thymus. Mol Endocrinol 6 (1992) 1513-1524
57. Von Patay B., Loppnow H., Feindt J., Kurz B., and Mentlein R. Catecholamines and lipopolysaccharide synergistically induce the release of interleukin-6 from thymic epithelial cells. J Neuroimmunol 86 (1998) 182-189
58. Singh U., and Owen J.J.T. Studies on the effect of various agents on the maturation of thymus stem cells. Eur J Immunol 5 (1975) 286-288
59. Singh U., and Owen J.J.T. Studies on the maturation of thymus stem cells. The effects of catecholamines, histamine, and peptide hormones on the expression of T allo-antigens. Eur J Immunol 6 (1976) 59-62
60. Singh U. Effect of catecholamines on lymphopoiesis in foetal mouse thymic explants. Eur J Immunol 14 (1979) 757-759
61. Singh U. Effect of catecholamines on lymphopoiesis in foetal mouse thymic explants. J Anat 129 (1979) 279-292
62. Singh U. Lymphopoiesis in the nude foetal mouse thymus following sympathectomy. Cell Immunol 93 (1985) 222-228
63. Singh U. Effect of sympathectomy on the maturation of foetal thymocytes grown within the anterior eye chambers in mice. Adv Exp Med Biol 186 (1985) 349-356
64. Durant S. In vivo effects of catecholamines and glucocorticoids on mouse thymic cAMP content and thymolysis. Cell Immunol 102 (1986) 136-143
65. Cook-Mills J.M., Cohen R.L., Perlman R.L., and Chambers D.A. Inhibition of lymphocyte activation by catecholamines: evidence for a non-classical mechanism of catecholamine action. Immunology 85 (1995) 544-549
66. Anderson K.L., Anderson G., Michell R.H., Jenkinson E.J., and Owen J.J. Intracellular signaling pathways involved in the induction of apoptosis in immature thymic T lymphocytes. J Immunol 156 (1996) 4083-4091
67. McConkey D.J., Orrenius S., and Jondal M. Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J Immunol 145 (1990) 1227-1230
68. Suzuki K., Tadakuma T., and Kizaki H. Modulation of thymocyte apoptosis by isoproterenol and prostaglandin E2. Cell Immunol 134 (1991) 235-240
69. Morgan J.I., Wigham C.G., and Perris A.D. The promotion of mitosis in cultured thymic lymphocytes by acetylcholine and catecholamines. J Pharm Pharmacol 36 (1984) 511-515
70. Delrue-Perollet C., Li K.S., Vitiello S., and Neveu P.J. Peripheral catecholamines are involved in the neuroendocrine and immune effects of LPS. Brain Behav Immun 9 (1995) 149-162
71. Tsao C.W., Cheng J.T., Shen C.L., and Lin Y.S. 6-Hydroxydopamine induces thymocyte apoptosis in mice. J Neuroimmunol 65 (1996) 91-95
72. Kostrzewa R.M., and Jacobwitz D.M. Pharmacological actions of 6-hydroxydopamine. Pharmacol Rev 26 (1974) 199-288
73. Rauski A., Kosec D., Vidic-Dankovic B., Plecas-Solarovic B., and Leposavic G. Effects of beta-adrenoceptor blockade on the phenotypic characteristics of thymocytes and peripheral blood lymphocytes. Int J Neurosci 113 (2003) 1653-1673
74. Rauski A., Kosec D., Vidic-Dankovic B., Radojevic K., Plecas-Solarovic B., and Leposavic G. Thymopoiesis following chronic blockade of beta-adrenoceptors. Immunopharmacol Immunotoxicol 25 (2003) 513-528
75. Blanco A., Artacho-Perula E., Flores-Acuna R., Moyano R., and Monterde J.G. Quantitative changes in the normal and apoptotic thymocytes of pigs treated with anabolic doses of the beta2 adrenergic agonist clenbuterol. Vet Immunol Immunopathol 96 (2003) 111-115
76. Madden K.S., and Felten D.L. Beta-adrenoceptor blockade alters thymocyte differentiation in aged mice. Cell Mol Biol Noisy le grand 47 (2001) 189-196
77. Madden K.S., Bellinger D.L., Felten S.Y., Snyder E., Maida M.E., and Felten D.L. Alterations in sympathetic innervation of thymus and spleen in aged mice. Mech Ageing Dev 94 (1997) 165-175
78. Plecas-Solarovic B., Hristic-Zivkovic I., Radojevic K., Kosec D., and Leposavic G. Chronic alpha1-adrenoreceptor blockade produces age-dependent changes in rat thymus structure and thymocyte differentiation. Histol Histopathol 20 (2005) 833-841
79. Colic M., Cupic V., Pavicic L., Vucevic D., and Varagic V.M. Xylazine, an alpha 2-adrenergic agonist, modulates proliferation of rat thymocytes in vivo and in vitro. Methods Find Exp Clin Pharmacol 22 (2000) 557-562
80. Cupic V., Colic M., Jandric D., Milojkovic B., and Varagic V.M. Xylazine, an alpha 2-adrenergic agonist, induces apoptosis of rat thymocytes and a thymocyte hybridoma line in vitro. Methods Find Exp Clin Pharmacol 25 (2003) 5-10
81. Le J.M., Fredrickson G., Reis L.F., et al. Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin 6. Proc Natl Acad Sci USA 85 (1988) 8643-8647
82. Weihe E., Nohr D., Michel S., et al. Molecular anatomy of the neuro-immune connection. Int J Neurosci 59 (1991) 1-23
83. Kaliner M., Orange R.P., and Austen K.F. Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. VI. Enhancement of cholinergic and alpha adrenergic stimulation. J Exp Med 136 (1972) 556-670
84. Tomita Y., Patterson R., and Suszko I.M. Respiratory mast cells and basophilic cells. II. Effects of pharmacological agents on 3′5′-adenosine monophosphate content and on antigen-induced histamine release. Int Arch Allergy Appl Immunol 47 (1974) 261-272
85. Bellinger D.L., Felten S.Y., Lorton D., and Felten D.L. Origin of noradrenergic innervation of the spleen in rats. Brain Behav Immun 3 (1989) 291-311
86. Nance D.M., and Burns J. Innervation of the spleen in the rat: evidence for absence of afferent innervation. Brain Behav Immun 3 (1989) 281-290
87. Chen S.H., Itoh M., Sun W., Miki T., and Takenuchi Y. Localization of sympatheatic and parasympathetic neurons innervating pancreas and spleen in the cat. J Auton Nerv Syst 59 (1996) 12-16
88. Trudrung P., Furness J.B., Pompolo S., and Messenger J.P. Locations and chemistries of sympathetic nerve cells that project to the gastrointestinal tract and spleen. Arch Histol Cytol 57 (1994) 139-150
89. Klein R.L., Wilson S.P., Dzielak D.J., Yang W.H., and Viveros O.H. Opioid peptides and noradrenaline co-exist in large dense-cored vesicles from sympathetic nerve. Neuroscience 7 (1982) 2255-2261
90. Ackerman K.D., Felten S.Y., Dijkstra C.D., Livnat S., and Felten D.L. Parallel development of noradrenergic innervation and cellular compartmentation in the rat spleen. Exp Neurol 103 (1989) 239-255
91. Ackerman K.D., Madden K.S., Livnat S., Felten S.Y., and Felten D.L. Neonatal sympathetic denervation alters the development of in vitro spleen cell proliferation and differentiation. Brain Behav Immun 5 (1991) 235-261
92. Fillenz M. Innervation of the cat spleen. Proc Physiol Soc 25-26 (1966) 2P-3P
93. Fillenz M. Innervation of blood vessels of lung and spleen. In: Karger B. (Ed). Sympathetic electric activation and innervation of blood vessels (1966), Cambridge, London 56-59
94. Romano T., Felten S.Y., Olschowka J.A., and Felten D.L. Noradrenergic and peptidergic innervation of lyphoid organs in the beluga, Delphinapterus leucas: an anatomical link between the nervous and immune systems. J Morphol 221 (1994) 243-259
95. Bellinger D.L., Ackerman K.D., Felten S.Y., and Felten D.L. A longitudinal study of age-related loss of noradrenergic nerves and lymphoid cells in the rat spleen. Exp Neurol 116 (1992) 295-311
96. Ackerman K.D., Felten S.Y., Bellinger D.L., and Felten D.L. Noradrenergic sympathetic innervation of the spleen: III. Development of innervation in the rat spleen. J Neurosci Res 18 (1987) 49-54 [see also 123-125]
97. Bellinger D.L., Felten S.Y., Collier T.J., and Felten D.L. Noradrenergic sympathetic innervation of the spleen: IV. Morphometric analysis in adult and aged F344 rats. J Neurosi Res 18 (1987) 55-63
98. Felten D.L., Ackerman K.D., Wiegand S.J., and Felten S.Y. Noradrenergic sympathetic innervation of the spleen: I. Nerve fibers associate with lymphocytes and macrophages in specific compartments of the splenic white pulp. J Neurosi Res 18 (1987) 28-36 [see also pages 118-126]
99. Felten S.Y., and Olschowka J.A. Noradrenergic sympathetic innervation of the spleen. II Tyrosine hydroxylase (TH)-positive nerve terminals from synaptic-like contacts on lymphocytes in the splenic white pulp. J Neurosi Res 18 (1987) 37-48
100. Stevens-Felten S.Y., and Bellinger D.L. Noradrenergic and peptidergic innervation of lymphoid organs. Chem Immunol 69 (1997) 99-131
101. Ueda H., Abe M., Takehana K., Iwasa K., and Hiraga T. Ultrastructure of the red pulp in spleen innervation in horse and pig. Acta Anat 141 (1991) 151-158
102. Elfvin J.G., Johansson J., Hoijer A.S., and Aldskogius H. The innervation of the splenic capsule in the guinea pig: an immunohistochemical and Ultrastructural study. J Anat 185 (1994) 267-278
103. Carlson S.L., Albers K.M., Beiting D.J., Parish M., Conner J.M., and Davis B.M. NGF modulates sympathetic innervation of lymphoid tissues. J Neurosci 15 (1995) 5892-5899
104. Bassett K., Molinaro C.A., Millar A.B., et al. Age-related changes in splenic neurotrophin content: a possible cause for declining sympathetic innervation in old rats. West Am Fed Med Res S55 (2005) 360
105. Lorton D., Lubahn C., Schaller, and Bellinger D. Noradrenergic (NA) nerves in spleens from rats with adjuvant arthritis (AA) undergo an injury and sprouting response that parallel changes in NGF-positive cells and NGF tissue levels. Brain Behav Immun 17 (2003) 186-187
106. Bellinger D.L., Lorton D., Hamill R.W., Felten S.Y., and Felten D.L. Acetylcholinesterase staining and choline acetyltransferase activity in the young adult rat spleen: lack of evidence for cholinergic innervation. Brain Behav Immun 7 (1993) 191-204
107. Fried G., Terenius L., Brodin E., et al. Neuropeptide Y, enkephalin and noradrenaline coexist in sympathetic neurons innervating the bovine spleen. Biochemical and immunohistochemical evidence. Cell Tissue Res 243 (1986) 495-508
108. Romano T.A., Felten S.Y., Felten D.L., and Olschowka J.A. Neuropeptide-Y innervation of the rat spleen: another potential immunomodulatory neuropeptide. Brain Behav Immun 5 (1991) 116-131
109. Giron L.T.J., Crutcher K.A., and Davis J.N. Lymph nodes-a possible site for sympathetic neuronal regulation of immune responses. Ann Neurol 8 (1980) 520-525
110. Fink T., and Weihe E. Multiple neuropeptides in nerves supplying mammalian lymph nodes: messenger candidates for sensory and autonomic neuroimmunomodulation?. Neurosci Lett 19 (1988) 39-44
111. Felten D.L., Livnat S., Felten S.Y., Carlson S.L., Bellinger D.L., and Yeh P. Sympathetic innervation of lymph nodes in mice. Brain Res Bull 13 (1984) 693-699
112. Ackerman K.D., Felten S.Y., Bellinger D.L., Livnat S., and Felten D.L. Noradrenergic sympathetic innervation of spleen and lymph nodes in relation to specific cellular compartments. In: Cinader B., and Miller R.G. (Eds). Progress in immunology IV (1987), Academic Press, Orlando 588-600
113. Felten D.L., Felten S.Y., Bellinger D.L., et al. Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol Rev 100 (1987) 225-260
114. Bellinger D.L., Ackerman K.D., Felten S.Y., Lorton D., and Felten D.L. Noradrenergic sympathetic innervation of thymus, spleen, and lymph nodes: aspects of development, aging, and plasticity in neural-immune interactions. In: Nistico G. (Ed). Proceedings of a symposium on interactions between the neuroendocrine and immune systems (1989), Pythagora Press, Milano Rome 35-66
115. Novotny G.E., and Kliche K.O. Innervation of lymph nodes: a combined silver impregnation and electron-microscopic study. Acta Anat Basel 127 (1986) 243-248
116. Novotny G.E.K. Ultrastructural analysis of lymph node innervation in the rat. Acta Anat 133 (1988) 57-61
117. Bienenstock J., Befus D., McDermott M., Mirski S., and Rosenthal K. Regulation of lymphoblast traffic and localization in mucosal tissues, with emphasis on IgA. Fed Proc 42 (1983) 3213-3217
118. Husband A.J. Kinetics of extravasation and redistribution of IgA-specific antibody-containing cells in the intestine. J Immunol 128 (1982) 1355-1359
119. Jeurissen S.H., Duijvestijn A.M., Sontag Y., and Kraal G. Lymphocyte migration into the lamina propria of the gut is mediated by specialized HEV-like blood vessels. Immunology 62 (1987) 273-277
120. Crivellato E., Soldano F., Travan L., Fusaroli P., and Mallardi F. Apposition of enteric nerve fibers to plasma cells and immunoblasts in the mouse small bowel. Neurosci Lett 241 (1998) 123-126
121. Ueyama T., Kozuki K., Houtani T., et al. Immunolocalization of tyrosine hydroxylase and vasoactive intestinal polypeptide in nerve fibers innervating human palatine tonsil and paratonsillar glands. Neurosci Lett 116 (1990) 70-74
122. Yamashita T., Kumazawa H., Kozuki K., Amano H., Tomoda K., and Kumazawa T. Autonomic nervous system in human palatine tonsil. Acta Otolaryngol Suppl 416 (1984) 63-71
123. Felten D.L., Overhage J.M., Felten S.Y., and Schmedtje J.F. Noradrenergic sympathetic innervation of lymphoid tissue in the rabbit appendix: further evidence for a link between the nervous and immune systems. Brain Res Bull 7 (1981) 595-612
124. Jesseph J.M., and Felten D.L. Noradrenergic innervation of the gut-associated lymphoid tissues (GALT) in the rabbit. Anat Rec 208 81A (1984)
125. Nohr D., and Weihe E. The neuroimmune link in the bronchus-associated lymphoid tissue (BALT) of cat and rat: peptides and neural markers. Brain Behav Immun 5 (1991) 84-101
126. Bidart J.M., Motte Ph., Assicot M., Bohuon C., and Bellet D. Catechol-O-methyltransferase activity and aminergic binding sites distribution in human peripheral blood lymphocyte subpopulations. Clin Immunol Immunopathol 26 (1983) 1-9
127. Bishopric N.H., Mcohen H.J., and Lefkowitz R.J. Beta-adrenergic receptors in lymphocyte subpopulations. J Allergy Clin Immunol 65 (1980) 29-33
128. Khan M.M., Sansoni P., Silverman E.D., Engleman E.G., and Melmon K.L. Beta-adrenergic receptors on human suppressor, helper, and cytolytic lymphocytes. Biol Psychiatry 35 (1986) 1137-1142
129. Krawietz W., Werdan K., Schober M., Erdmann E., Rindfleisch G.E., and Hannig K. Different numbers of beta-receptors in human lymphocyte subpopulations. Biochem Pharmacol 31 (1982) 4613-4620
130. Loveland B.E., Jarrott B., and McKenzie I.F. The detection of beta-adrenoceptors on murine lymphocytes. Intl J Immunopharmacol 3 (1981) 45-55
131. Pochet R., and Delespesse G. Beta-adrenoceptors display different efficiency on lymphocyte subpopulations. Biochem Pharmacol 32 (1983) 1651-1655
132. Pochet R., Delespesse G., Gausset P.W., and Collet H. Distribution of beta-adrenergic receptors on human lymphocyte subpopulations. Clin Exper Immunol 38 (1979) 578-584
133. Van Tits L.J., Michel M.C., Grosse-Wilde H., et al. Catecholamines increase lymphocyte beta-2-adrenergic receptors via a beta-2-adrenergic, spleen-dependent process. Am J Physiol 258 (1990) E191-E202
134. Westly H.J., and Kelley K.W. Down-regulation of glucocorticoid and beta-adrenergic receptors on lectin-stimulated splenocytes. Proc Soc Exp Biol Med 185 (1987) 211-218
135. 3H-alprenolol binding. J Clin Invest 57 (1976) 149-155
136. Bourne H.R., and Melmon K.L. Adenyl cyclase in human leukocytes: Evidence for activation by separate beta adrenergic and prostaglandin receptors. J Pharmacol Exper Ther 178 (1971) 1-7
137. Conolly M.E., and Greenacre J.K. The beta-adrenoceptor of the human lymphocyte and human lung parenchyma. Br J Pharmacol 59 (1977) 17-23
138. 3H]dihydroalprenolol binding to intact and broken cell preparations of human peripheral blood lymphocytes. Eur J Pharmacol 85 (1982) 185-194
139. Ramer-Quinn D.S., Baker R.A., and Sanders V.M. Activated Th1 and Th2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of Th1 cell cytokine production. J Immunol 159 (1997) 4857-4867
140. Sanders V.M., Baker R.A., Ramer-Quinn D.S., Kasprowicz D.J., Fuchs B.A., and Street N.E. Differential expression of the beta-2-adrenergic receptor by Th1 and Th2 clones: implication for cytokine production and B cell help. J Immunol 158 (1997) 4200-4210
141. Swanson M.A., Lee W.T., and Sanders V.M. IFN-gamma production by Th1 cells generated from naive CD4+T cells exposed to norepinephrine. J Immunol 166 (2001) 232-240
142. Kohm A.P., Mozaffarian A., and Sanders V.M. B cell receptor- and beta 2-adrenergic receptor-induced regulation of B7-2 (CD86) expression in B cells. J Immunol 168 (2002) 6314-6322
143. Sanders V.M., and Munson A.E. Role of alpha adrenoceptor activation in modulating the murine primary antibody response in vitro. J Pharmacol Exper Ther 232 (1985) 395-400
144. Cazaux C.A., Sterin-Borda L., Gorelik G., and Cremaschi G.A. Down-regulation of beta-adrenergic receptors induced by mitogen activation of intracellular signaling events in lymphocytes. Fed Eur Biochem Soc 364 (1995) 120-124
145. Madden K.S., Felten S.Y., Felten D.L., Sundaresan P.R., and Livnat S. Sympathetic neuronal modulation of the immune system. I. Depression of T cell immunity in vivo and vitro following chemical sympathectomy. Brain Behav Immun 3 (1989) 72-89
146. Bartik M.M., Bauman G.P., Brooks W.H., and Roszman T.L. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells. Cell Immunol 158 (1994) 116-130
147. Brodde O.E., Daul A., and O'Hara N. Beta-adrenoceptor changes in human lymphocytes, induced by dynamic exercise. Naunyn Schmiedebergs Arch Pharmacol 325 (1984) 190-192
148. Makman M.H. Properties of adenylate cyclase of lymphoid cells. Proc Natl Acad Sci USA 68 (1971) 885-889
149. Bauman G.P., Bartik M.M., Brooks W.H., and Roszman T.L. Induction of cAMP-dependent protein kinase (PKA) activity in T cells after stimulation of the prostaglandin E2 or the beta-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation. Cell Immunol 158 (1994) 182-194
150. DeRubertis F.R., Zenser T.V., Adler W.H., and Hudson T. Role of cyclic adenosine 3',5'-monophosphate in lymphocyte mitogenesis. J Immunol 113 (1974) 151-161
151. Diamantstein T., and Ulmer A. The antagonistic action of cyclic GMP and cyclic AMP on proliferation of B and T lymphocytes. Immunology 28 (1975) 113-119
152. Estes G., Solomon S.S., and Norton W.L. Inhibition of lymphocyte stimulation by cyclic and non-cyclic nucleotides. J Immunol 107 (1971) 1489-1492
153. Ledbetter J.A., Parsons M., Martin P.J., Hansen J.A., Rabinovitch P.S., and June C.H. Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: effects on cyclic nucleotides, cytoplasmic free calcium, and cAMP-mediated suppression. J Immunol 137 (1986) 3299-3305
154. Smith J.W., Steiner A.L., and Parker C.W. Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin. J Clin Invest 50 (1971) 442-448
155. Vischer T.L. The differential effect of cyclic AMP on lymphocyte stimulation by T- or B-cell mitogens. Immunology 30 (1976) 735-739
156. Weinstein Y., Segal S., and Melmon K.L. Specific mitogenic activity of 8-Br-guanosine 3′, 5′-monophosphate (Br-cyclic GMP) on B lymphocytes. J Immunol 115 (1975) 112-117
157. Cremaschi G.A., Fisher P., and Boege F. Beta-adrenoceptor distribution in murine lymphoid cell lines. Immunopharmacology 22 (1991) 195-206
158. Miles K., Atweh S., Otten G., Arnason B.G., and Chelmicka-Schorr E. Beta-adrenergic receptors on splenic lymphocytes from axotomized mice. Int J Immunopharmacol 6 (1984) 171-177
159. Miles K., Chelmicka-Schorr E., Atweh S., Otten G., and Arnason B.G. Sympathetic ablation alters lymphocyte membrane properties. J Immunol 135 Suppl. 2 (1985) 797s-801s
160. Kohm A.P., and Sanders V.M. Suppression of antigen-specific Th2 cell-dependent IgM and IgG1 production following norepinephrine depletion in vivo. J Immunol 162 (1999) 5299-5308
161. Kasprowicz D.J., Kohm A.P., Berton M.T., Chruscinski A.J., Sharpe A., and Sanders V.M. Stimulation of the B cell receptor, CD86 (B7-2), and the beta 2-adrenergic receptor intrinsically modulates the level of IgG1 and IgE produced per B cell. J Immunol 165 (2000) 680-690
162. Blomhoff H.K., Smeland E.B., Beiske K., et al. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes. J Cell Physiol 131 (1987) 426-433
163. Cohen D.P., and Rothstein T.L. Adenosine 3′,5′-cyclic monophosphate modulates the mitogenic responses of murine B lymphocytes. Cell Immunol 121 (1989) 113-124
164. Muthusamy N., Baluyut A.R., and Subbarao B. Differential regulation of surface Ig- and Lyb2-mediated B cell activation by cyclic AMP. I. Evidence for alternative regulation of signaling through two different receptors linked to phosphatidylinositol hydrolysis in murine B cells. J Immunol 147 (1991) 2483-2492
165. Whisler R.L., Beiqing L., Grants I.S., and Newhouse Y.G. Cyclic AMP modulation of human B cell proliferative responses: role of cAMP-dependent protein kinases in enhancing B cell responses to phorbol diesters and ionomycin. Cell Immunol 142 (1992) 398-415
166. Holte H., Torjesen P., Blomhoff H.K., Ruud E., Funderud S., and Smeland E.B. Cyclic AMP has the ability to influence multiple events during B cell stimulation. Eur J Immunol 18 (1988) 1359-1366
167. Li Y.S., Kouassi E., and Revillard J.P. Cyclic AMP can enhance mouse B cell activation by regulating progression into the late G1/S phase. Eur J Immunol 19 (1989) 1721-1725
168. Jetschmann J.U., Benschop R.J., Jacobs R., et al. Expression and in vivo modulation of alpha- and beta-adrenoceptors on human natural killer (CD16+) cells. J Neuroimmunol 74 (1997) 159-164
169. Benschop R.J., Oostveen F.G., Heijnen C.J., and Ballieux R.E. Beta 2-adrenergic stimulation causes detachment of natural killer cells from cultured endothelium. Eur J Immunol 23 (1993) 3242-3247
170. Maisel A.S., Harris T., Rearden C.A., and Michel M.C. Beta-adrenergic receptors in lymphocyte subsets after exercise. Alterations in normal individuals and patients with congestive heart failure. Circulation 82 (1990) 2003-2010
171. Takamoto T., Hori Y., Koga Y., Toshima H., Hara A., and Yokoyama M.M. Norepinephrine inhibits human natural killer cell activity in vitro. Int J Neurosci 58 (1991) 127-131
172. Whalen M.M., and Bankhurst A.D. Effects of beta-adrenergic receptor activation, cholera toxin and forskolin on human natural killer cell function. Biochem J 272 (1990) 327-331
173. Murray D.R., Irwin M., Rearden C.A., Ziegler M., Motulsky H., and Maisel A.S. Sympathetic and immune interactions during dynamic exercise. Mediation via a beta 2-adrenergic-dependent mechanism. Circulation 86 (1992) 203-213
174. Schedlowski M., Hosch W., Oberbeck R., et al. Catecholamines modulate human NK cell circulation and function via spleen-independent beta 2-adrenergic mechanisms. J Immunol 156 (1996) 93-99
175. Spengler R.N., Allen R.M., Remick D.G., Strieter R.M., and Kunkel S.L. Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J Immunol 145 (1990) 1430-1434
176. Abrass C.K., O'Connor S.W., Scarpace P.J., and Abrass I.B. Characterization of the beta-adrenergic receptor of the rat peritoneal macrophage. J Immunol 135 (1985) 1338-1341
177. Rosati C., Hannaert P., Dausse J.P., Braquet P., and Garay R. Stimulation of beta-adrenoceptors inhibits calcium-dependent potassium-channels in mouse macrophages. J Cell Physiol 129 (1986) 310-314
178. Hjemdahl P., Larsson K., Johansson M.C., Zetterlund A., and Eklund A. Beta-adrenoceptors in human alveolar macrophages isolated by elutriation. Br J Clin Pharmacol 30 (1990) 673-682
179. Liggett S.B. Identification and characterization of a homogeneous population of beta 2-adrenergic receptors on human alveolar macrophages. Am Rev Respir Dis 139 (1989) 552-555
180. Henricks P.A., Van Esch B., Van Oosterhout A.J., and Nijkamp F.P. Specific and non-specific effects of beta-adrenoceptor agonists on guinea pig alveolar macrophage function. Eur J Pharmacol 152 (1988) 321-330
181. van Esch B., Henricks P.A., van Oosterhout A.J., and Nijkamp F.P. Guinea pig alveolar macrophages possess beta-adrenergic receptors. Agents Actions 26 (1989) 123-124
182. Remold-O'Donnell E. Stimulation and desensitization of macrophage adenylate cyclase by prostaglandins and catecholamines. J Biol Chem 249 (1974) 3615-3621
183. Higgins T.J., and David J.R. Effect of isoproterenol and aminiphylline on cyclic AMP levels of guinea pig macrophages. Cell Immunol 27 (1976) 1-10
184. Ikegami K. Modulation of adenosine 3′,5′-monophosphate contents of rat peritoneal macrophages mediated by beta2-adrenergic receptors. Biochem Pharmacol 26 (1977) 1813-1816
185. Lavis V.R., Strada S.J., Ross C.P., Hersh E.M., and Thompson W.J. Comparison of the responses of freshly isolated and cultured human monocytes and P388D1 cells to agents affecting cyclic AMP metabolism. J Lab Clin Med 96 (1980) 551-561
186. Verghese M.W., and Snyderman R. Hormonal activation of adenylate cyclase in macrophage membranes is regulated by guanine nucleotides. J Immunol 130 (1983) 869-873
187. Welscher H.D., and Cruchaud A. The influence of various particles and 3′, 5′ cyclic adenosine monophosphate on release of lysosomal enzymes by mouse macrophages. J Reticuloendothel Soc 20 (1976) 405-420
188. Hara N., Ichinose M., Sawada M., and Maeno T. The activation of Ca(2+)-dependent K+ conductance by adrenaline in mouse peritoneal macrophages. Pflugers Arch 419 (1991) 371-379
189. Young J.D., Ko S.S., and Cohn Z.A. The increase in intracellular free calcium associated with IgG gamma 2b/gamma 1 Fc receptor-ligand interactions: role in phagocytosis. Proc Natl Acad Sci USA 81 (1984) 5430-5434
190. Sanders PNI II chapter.
191. Bartik M.M., Brooks W.H., and Roszman T.L. Modulation of T cell proliferation by stimulation of the beta-adrenergic receptor: lack of correlation between inhibition of T cell proliferation and cAMP accumulation. Cell Immunol 148 (1993) 408-421
192. Carlson S.L., Brooks W.H., and Roszman T.L. Neurotransmitter-lymphocyte interactions: dual receptor modulation of lymphocyte proliferation and cAMP production. J Neuroimmunol 24 (1989) 155-162
193. Carlson S.L., Trauth K., Brooks W.H., and Roszman T.L. Enhancement of beta-adrenergic-induced cAMP accumulation in activated T-cells. J Cell Physiol 161 (1994) 39-48
194. Hadden J.W., Hadden E.M., and Middleton Jr. E. Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell Immunol 1 (1970) 583-595
195. Johnson D.L., Ashmore R.C., and Gordon M.A. Effects of beta-adrenergic agents on the murine lymphocyte response to mitogen stimulation. J Immunopharmacol 3 (1981) 205-219
196. Johnson D.L., and Gordon M.A. Effect of chronic beta-adrenergic therapy on the human lymphocyte response to concanavalin A. Res Commun Chem Pathol Pharmacol 32 (1981) 377-380
197. Betz M., and Fox B.S. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 146 (1991) 108-113
198. Gajewski T.F., Schell S.R., and Fitch F.W. Evidence implicating utilization of different T cell receptor-associated signaling pathways by TH1 and TH2 clones. J Immunol 144 (1990) 4110-4120
199. Qiu Y., Peng Y., and Wang J. Immunoregulatory role of neurotransmitters. Adv Neuroimmunol 6 (1996) 223-231
200. Feldman R.D., Hunninghake G.W., and McArdle W.L. Beta-adrenergic-receptor-mediated suppression of interleukin 2 receptors in human lymphocytes. J Immunol 139 (1987) 3355-3359
201. Krause D.S., and Deutsch C. Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: expression of both p55 and p75 subunits is affected. J Immunol 146 (1991) 2285-2296
202. 2+ and cyclic AMP-dependent protein kinases. J Biol Chem 264 (1989) 14498-14502
203. Novak T.J., and Rothenberg E.V. cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc Natl Acad Sci USA 87 (1990) 9353-9357
204. Selliah N., Bartik M.M., Carlson S.L., Brooks W.H., and Roszman T.L. cAMP accumulation in T-cells inhibits anti-CD3 monoclonal antibody-induced actin polymerization. J Neuroimmunol 56 (1995) 107-112
205. Wacholtz M.C., Minakuchi R., and Lipsky P.E. Characterization of the 3′,5′-cyclic adenosine monophosphate-mediated regulation of IL2 production by T cells and Jurkat cells. Cell Immunol 135 (1991) 285-298
206. Ramer-Quinn D.S., Swanson M.A., Lee W.T., and Sanders V.M. Cytokine production by naive and primary effector CD4+T cells exposed to norepinephrine. Brain Behav Immun 14 (2000) 239-255
207. Katamura K., Shintaku N., Yamauchi Y., et al. Prostaglandin E2 at priming of naive CD4+T cells inhibits acquisition of ability to produce IFN-gamma and IL-2, but not IL-4 and IL-5. J Immunol 155 (1995) 4604-4612
208. Paliogianni F., and Boumpas D.T. Prostaglandin E2 inhibits the nuclear transcription of the human interleukin 2, but not the IL-4, gene in human T cells by targeting transcription factors AP-1 and NF-AT. Cell Immunol 171 (1996) 95-101
209. Yoshimura T., Nagao T., Nakao T., et al. Modulation of Th1- and Th2-like cytokine production from mitogen-stimulated human peripheral blood mononuclear cells by phosphodiesterase inhibitors. Gen Pharmacol 30 (1998) 175-180
210. Borger P., Kauffman H.F., Postma D.S., and Vellenga E. Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway. Blood 87 (1996) 691-698
211. Crocker I.C., Townley R.G., and Khan M.M. Phosphodiesterase inhibitors suppress proliferation of peripheral blood mononuclear cells and interleukin-4 and -5 secretion by human T-helper type 2 cells. Immunopharmacology 31 (1996) 223-235
212. Lacour M., Arrighi J.F., Muller K.M., Carlberg C., Saurat J.H., and Hauser C. cAMP up-regulates IL-4 and IL-5 production from activated CD4+T cells while decreasing IL-2 release and NF-AT induction. Int Immunol 6 (1994) 1333-1343
213. Wirth S., Lacour M., Jaunin F., and Hauser C. Cyclic adenosine monophosphate (cAMP) differentially regulates IL-4 in thymocyte subsets. Thymus 24 (1996) 101-109
214. Madden K.S., Moynihan J.A., Brenner G.J., Felten S.Y., Felten D.L., and Livnat S. Sympathetic nervous system modulation of the immune system. III. Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy. J Neuroimmunol 49 (1994) 77-87
215. Hatfield S.M., Petersen B.H., and DiMicco J.A. Beta adrenoceptor modulation of the generation of murine cytotoxic T lymphocytes in vitro. J Pharmacol Exp Ther 239 (1986) 460-466
216. Cook-Mills J.M., Mokyr M.B., Cohen R.L., Perlman R.L., and Chambers D.A. Neurotransmitter suppression of the in vitro generation of a cytotoxic T lymphocyte response against the syngeneic MOPC-315 plasmacytoma. Cancer Immunol Immunother 40 (1995) 79-87
217. Strom T.B., Carpenter C.B., Garovoy M.R., Austen K.F., Merrill J.P., and Kaliner M. The modulating influence of cyclic nucleotides upon lymphocyte-mediated cytotoxicity. J Exp Med 138 (1973) 381-393
218. Bender B.S., Bell W.E., Taylor S., and Scarpace P.J. Decreased sensitivity to cAMP in the in vitro generation of memory splenic cytotoxic T-lymphocytes from aged mice: role of phosphodiesterase. J Pharmacol Exp Ther 264 (1993) 1381-1386
219. Takayama H., Trenn G., and Sitkovsky M.V. Locus of inhibitory action of cAMP-dependent protein kinase in the antigen receptor-triggered cytotoxic T lymphocyte activation pathway. J Biol Chem 263 (1988) 2330-2336
220. Kouassi E., Li Y.S., Boukhris W., Millet I., and Revillard J.P. Opposite effects of the catecholamines dopamine and norepinephrine on murine polyclonal B-cell activation. Immunopharmacology 16 (1988) 125-137
221. Burchiel S.W., and Melmon K.L. Augmentation of the in vitro humoral immune response by pharmacologic agents. I: an explanation for the differential enhancement of humoral immunity via agents that elevate cAMP. Immunopharmacology 1 (1979) 137-150
222. Gilbert K.M., and Hoffmann M.K. cAMP is an essential signal in the induction of antibody production by B cells but inhibits helper function of T cells. J Immunol 135 (1985) 2084-2089
223. Melmon K.L., Bourne H.R., Weinstein Y., Shearer G.M., Kram J., and Bauminger S. Hemolytic plaque formation by leukocytes in vitro. Control by vasoactive hormones. J Clin Invest 53 (1974) 13-21
224. Patke C.L., Orson F.M., and Shearer W.T. Cyclic AMP-mediated modulation of immunoglobulin production in B cells by prostaglandin E1. Cell Immunol 137 (1991) 36-45
225. Watson J., Epstein R., and Cohn M. Cyclic nucleotides as intracellular mediators of the expression of antigen-sensitive cells. Nature 246 (1973) 405-409
226. Hall N.R., McClure J.E., Hu S.K., Tare N.S., Seals C.M., and Goldstein A.L. Effects of 6-hydroxydopamine upon primary and secondary thymus dependent immune responses. Immunopharmacology 5 (1982) 39-48
227. Kasahara K., Tanaka S., and Hamashima Y. Suppressed immune response to T-cell dependent antigen in chemically sympathectomized mice. Res Commun Chem Pathol Pharmacol 18 (1977) 533-542
228. Livnat S., Felten S.Y., Carlson S.L., Bellinger D.L., and Felten D.L. Involvement of peripheral and central catecholamine systems in neural-immune interactions. J Neuroimmunol 10 (1985) 5-30
229. Chelmicka-Schorr E., Checinski M., and Arnason B.G. Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis. J Neuroimmunol 17 (1988) 347-350
230. Miles K., Quintans J., Chelmicka-Schorr E., and Arnason B.G. The sympathetic nervous system modulates antibody response to thymus-independent antigens. J Neuroimmunol 1 (1981) 101-105
231. Kruszewska B., Felten S.Y., and Moynihan J.A. Alterations in cytokine and antibody production following chemical sympathectomy in two strains of mice. J Immunol 155 (1995) 4613-4620
232. Kruszewska B., Felten D.L., Stevens S.Y., and Moynihan J.A. Sympathectomy-induced immune changes are not abrogated by the glucocorticoid receptor blocker RU-486. Brain Behav Immun 12 (1998) 181-200
233. Esquifino A.I., and Cardinali D.P. Local regulation of the immune response by the autonomic nervous system. Neuroimmunomodulation 1 (1994) 265-273
234. Sanders V.M., and Munson A.E. Kinetics of the enhancing effect produced by norepinephrine and terbutaline on the murine primary antibody response in vitro. J Pharmacol Exp Ther 231 (1984) 527-531
235. Sanders V.M., and Munson A.E. Beta adrenoceptor mediation of the enhancing effect of norepinephrine on the murine primary antibody response in vitro. J Pharmacol Exp Ther 230 (1984) 183-192
236. Sanders V.M., and Powell-Oliver F.E. Beta 2-adrenoceptor stimulation increases the number of antigen-specific precursor B lymphocytes that differentiate into IgM-secreting cells without affecting burst size. J Immunol 148 (1992) 1822-1828
237. Madden K.S., Felten S.Y., Felten D.L., Hardy C.A., and Livnat S. Sympathetic nervous system modulation of the immune system. II. Induction of lymphocyte proliferation and migration in vivo by chemical sympathectomy. J Neuroimmunol 49 (1994) 67-75
238. Callahan T.A., and Moynihan J.A. Contrasting pattern of cytokines in antigen- versus mitogen-stimulated splenocyte cultures from chemically denervated mice. Brain Behav Immun 16 (2002) 764-773
239. Felsner P., Hofer D., Rinner I., Porta S., Korsatko W., and Schauenstein K. Adrenergic suppression of peripheral blood T cell reactivity in the rat is due to activation of peripheral alpha 2-receptors. J Neuroimmunol 57 (1995) 27-34
240. Fuchs B.A., McCall C.O., and Munson A.E. Enhancement of the murine primary antibody response by phenylephrine in vitro. Drug Chem Toxicol 14 (1991) 67-82
241. Heilig M., Irwin M., Grewal I., and Sercarz E. Sympathetic regulation of T-helper cell function. Brain Behav Immun 7 (1993) 154-163
242. Brown R., Li Z., Vriend C.Y., et al. Suppression of splenic macrophage interleukin-1 secretion following intracerebroventricular injection of interleukin-1: evidence for pituitary-adrenal and sympathetic control. Cell Immunol 132 (1991) 84-93
243. Henricks P.A., van Esch B., and Nijkamp F.P. Beta-agonists can depress oxidative metabolism of alveolar macrophages. Agents Actions 19 (1986) 353-354
244. Henricks P.A., Verhoef J., and Nijkamp F.P. Modulation of phagocytic cell function. Vet Res Commun 10 (1986) 165-188
245. Schopf R.E., and Lemmel E.M. Control of the production of oxygen intermediates of human polymorphonuclear leukocytes and monocytes by beta-adrenergic receptors. J Immunopharmacol 5 (1983) 203-216
246. Fukushima T., Sekizawa K., Jin Y., Yamaya M., Sasaki H., and Takishima T. Effects of beta-adrenergic receptor activation on alveolar macrophage cytoplasmic motility. Am J Physiol 265 (1993) L67-L72
247. Conlon P.D., Ogunbiyi P.O., Black W.D., and Eyre P. Beta-adrenergic receptor function and oxygen radical production in bovine pulmonary alveolar macrophages. Can J Physiol Pharmacol 66 (1988) 1538-1541
248. Fuller R.W., O'Malley G., Baker A.J., and MacDermot J. Human alveolar macrophage activation: inhibition by forskolin but not beta-adrenoceptor stimulation or phosphodiesterase inhibition. Pulm Pharmacol 1 (1988) 101-106
249. -) release from alveolar macrophages of patients with chronic bronchitis. Chest 104 (1993) 481-486
250. Balter N.J., and Schwartz S.L. Accumulation of norepinephrine by macrophages and relationships to known uptake processes. J Pharmacol Exp Ther 201 (1977) 636-643
251. Issaad C., Ventura M.A., and Thomopoulos P. Biphasic regulation of macrophage attachment by activators of cyclic adenosine monophosphate-dependent kinase and protein kinase C. J Cell Physiol 140 (1989) 317-322
252. Serio M., Potenza M.A., Montagnani M., Mansi G., Mitolo-Chieppa D., and Jirillo E. Beta-adrenoceptor responsiveness of splenic macrophages in normotensive and hypertensive rats. Immunopharmacol Immunotoxicol 18 (1996) 247-265
253. Spengler R.N., Chensue S.W., Giacherio D.A., Blenk N., and Kunkel S.L. Endogenous norepinephrine regulates tumor necrosis factor-alpha production from macrophages in vitro. J Immunol 152 (1994) 3024-3031
254. Petty H.R., and Berg K.A. Combinative ligand-receptor interactions: epinephrine depresses RAW264 macrophage antibody-dependent phagocytosis in the absence and presence of met-enkephalin. J Cell Physiol 134 (1988) 281-286
255. Chelmicka-Schorr E., Kwasniewski M.N., and Czlonkowska A. Sympathetic nervous system modulates macrophage function. Int J Immunopharmacol 14 (1992) 841-846
256. Chelmicka-Schorr E., Kwasniewski M.N., and Czlonkowska A. Sympathetic nervous system and macrophage function. Ann NY Acad Sci 650 (1992) 40-45
257. Koff W.C., and Dunegan M.A. Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones. J Immunol 135 (1985) 350-354
258. Javierre M.Q., Pinto L.V., Lima A.O., and Sassine W.A. Immunologic phagocytosis by macrophages: effect by stimulation of alpha adrenergic receptors. Rev Bras Pesqui Med Biol 8 (1975) 271-274
259. Lappin D., and Whaley K. Adrenergic receptors on monocytes modulate complement component synthesis. Clin Exp Immunol 47 (1982) 606-612
260. Hellstrand K., Hermodsson S., and Strannegard O. Evidence for a beta-adrenoceptor-mediated regulation of human natural killer cells. J Immunol 134 (1985) 4095-4099
261. Benschop R.J., Nijkamp F.P., Ballieux R.E., and Heijnen C.J. The effects of beta-adrenoceptor stimulation on adhesion of human natural killer cells to cultured endothelium. Br J Pharmacol 113 (1994) 1311-1316
262. Benschop R.J., Schedlowski M., Wienecke H., Jacobs R., and Schmidt R.E. Adrenergic control of natural killer cell circulation and adhesion. Brain Behav Immun 11 (1997) 321-332
263. Shakhar G., and Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J Immunol 160 (1998) 3251-3258
264. Bachen E.A., Manuck S.B., Cohen S., et al. Adrenergic blockade ameliorates cellular immune responses to mental stress in humans. Psychosom Med 57 (1995) 366-372
265. Marsland A.L., Manuck S.B., Wood P., Rabin B.S., Muldoon M.F., and Cohen S. Beta 2-adrenergic receptor density and cardiovascular response to mental stress. Physiol Behav 57 (1995) 1163-1167
266. Shakhar G., and Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J Immunol 160 (1998) 3251-3258
267. Brenner G.J., Felten S.Y., Felten D.L., and Moynihan J.A. Sympathetic nervous system modulation of tumor metastases and host defense mechanisms. J Neuroimmunol 37 (1992) 191-201
268. Irwin M., Hauger R.L., Brown M., and Britton K.T. CRF activates autonomic nervous system and reduces natural killer cytotoxicity. Am J Physiol 255 (1988) R744-R747
269. Irwin M., Hauger R.L., Jones L., Provencio M., and Britton K.T. Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity. J Pharmacol Exp Ther 255 (1990) 101-107
270. Mills P.J., Karnik R.S., and Dillon E. L-selectin expression affects T-cell circulation following isoproterenol infusion in humans. Brain Behav Immun 11 (1997) 333-342
271. Gonzalez-Ariki S., and Husband A.J. The role of sympathetic innervation of the gut in regulating mucosal immune responses. Brain Behav Immun 12 (1998) 53-63
272. Carlson S.L., Fox S., and Abell K.M. Catecholamine modulation of lymphocyte homing to lymphoid tissues. Brain Behav Immun 11 (1997) 307-320
273. Ernstrom U., and Sandberg G. Effects of adrenergic alpha- and beta-receptor stimulation on the release of lymphocytes and granulocytes from the spleen. Scand J Haematol 11 (1973) 275-286
274. Rogausch H., del Rey A., Oertel J., and Besedovsky H.O. Norepinephrine stimulates lymphoid cell mobilization from the perfused rat spleen via beta-adrenergic receptors. Am J Physiol 276 (1999) R724-R730
275. Abbas A.K., Murphy K.M., and Sher A. Functional diversity of helper T lymphocytes. Nat London 383 (1996) 787-793
276. Fearon D.T., and Locksley R.M. The instructive role of innate immunity in the acquired immune response. Sci Wash DC 272 (1996) 50-53
277. Mosmann T.R., and Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17 (1996) 138-146
278. Elenkov I.J., Wilder R.L., Chrousos G.P., and Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52 (2000) 595-638
279. Lerner B.H. Can stress cause disease? Revisiting the tuberculosis research of Thomas Holmes 1949-1961. Ann Intern Med 124 (1996) 673-680
280. Altare F., Durandy A., Lammas D., et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Sci Wash DC 280 (1998) 1432-1435
281. Elenkov I.J., Papanicolaou D.A., Wilder R.L., and Chrousos G.P. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc Assoc Am Physicians 108 (1996) 374-381
282. Elenkov I.J., and Chrousos G.P. Stress hormones, Th1/Th2 patterns, pro/antiinflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab 10 (1999) 359-368
283. Levenstein S. Stress and peptic ulcer: life beyond Helicobacter. Br Med J 316 (1998) 538-541
284. Levenstein S., Ackerman S., Kiecolt-Glaser J.K., and Dubois A. Stress and peptic ulcer disease. J Am Med Assoc 281 (1999) 10-11
285. Katoh K., Nomura M., Nakaya Y., et al. Autonomic nervous activity before and after eradication of Helicobacter pylori in patients with chronic duodenal ulcer. Aliment Pharmacol Ther 16 suppl. 2 (2002) 180-186
286. Elenkov I.J., Webster E., Papanicolaou D.A., Fleisher T.A., Chrousos G.P., and Wilder R.L. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol 161 (1998) 2586-2593
287. Haraguchi S., Good R.A., and Day N.K. Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol Today 16 (1995) 595-603
288. Cole S.W., Korin Y.D., Fahey J.L., and Zack J.A. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Immunol 161 (1998) 610-616
289. Haraguchi S., Good R.A., James-Yarish M., Cianciolo G.J., and Day N.K. Differential modulation of Th1- and Th2-related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein. Proc Natl Acad Sci USA 92 (1995) 3611-3615
290. Haraguchi S., Good R.A., James-Yarish M., Cianciolo G.J., and Day N.K. Induction of intracellular cAMP by a synthetic retroviral envelope peptide: a possible mechanism of immunopathogenesis in retroviral infections. Proc Natl Acad Sci USA 92 (1995) 5568-5571
291. Kelley S.P., Moynihan J.A., Stevens S.Y., Grota L.J., and Felten D.L. Chemical sympathectomy has no effect on the severity of murine AIDS: murine AIDS alone depletes norepinephrine levels in infected spleen. Brain Behav Immun 16 (2002) 118-139
292. Kelley S.P., Moynihan J.A., Stevens S.Y., Grota L.J., and Felten D.L. Sympathetic nerve destruction in spleen in murine AIDS. Brain Behav Immun 17 (2003) 94-109
293. Pastores S.M., Hasko G., Vizi E.S., and Kvetan V. Cytokine production and its manipulation by vasoactive drugs. New Horiz 4 (1996) 252-264
294. Eigler A., Sinha B., Hartmann G., and Endres S. Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol Today 18 (1997) 487-492
295. Palsson J., Ricksten S.E., Delle M., and Lundin S. Changes in renal sympathetic nerve activity during experimental septic and endotoxin shock in conscious rats. Circ Shock 24 (1988) 133-141
296. Jones S.B., Kovarik M.F., and Romano F.D. Cardiac and splenic norepinephrine turnover during septic peritonitis. Am J Physiol 250 (1986) R892-R897
297. Leinhardt D.J., Arnold J., Shipley K.A., Mughal M.M., Little R.A., and Irving M.H. Plasma NE concentrations do not accurately reflect sympathetic nervous system activity in human sepsis. Am J Physiol 265 (1993) E284-E288
298. Zhou M., Hank Simms H., and Wang P. Increased gut-derived norepinephrine release in sepsis: up-regulation of intestinal tyrosine hydroxylase. Biochim Biophys Acta 1689 (2004) 212-218
299. Miura T., Kudo T., Matsuki A., Sekikawa K., Tagawa Y., Iwakura Y., et al. Effect of 6-hydroxydopamine on host resistance against Listeria monocytogenes infection. Infect Immun 69 (2001) 7234-7241
300. Straub R.H., Linde H.J., Männel D.N., Schölmerich J., and Falk W. A bacteria-induced switch of sympathetic effector mechanisms augments local inhibition of TNF-α and IL-6 secretion in the spleen. FASEB J 14 (2000) 1380-1388
301. Rice P.A., Boehm G.W., Moynihan J.A., Bellinger D.L., and Stevens S.Y. Chemical sympathectomy increases the innate immune response and decreases the specific immune response in the spleen to infection with Listeria monocytogenes. J Neuroimmunol 114 (2001) 19-27
302. Straub R.H., Pongratz G., Weidler C., et al. Ablation of the sympathetic nervous system decreases gram-negative and increases gram-positive bacterial dissemination: key roles for tumor necrosis factor/phagocytes and interleukin-4/lymphocytes. J Infect Dis 192 (2005) 560-572
303. Cao L., Hudson C.A., and Lawrence D.A. Acute cold/restraint stress inhibits host resistance to Listeria monocytogenes via ß1-adrenergic receptors. Brain Behav Immun 17 (2003) 121-133
304. Green B.T., Lyte M., Chen C., et al. Adrenergic modulation of Escherichia coli O157:H7 adherence to the colonic mucosa. Am J Physiol Gastrointest Liver Physiol 287 (2004) G1238-G1246
305. Takahashi H., Kobayashi M., Tsuda Y., Herndon D.N., and Suzuki F. Contribution of the sympathetic nervous system on the burn-associated impairment of CCL3 production. Cytokine 29 (2005) 208-214
306. Redwine L., Snow S., Mills P., and Irwin M. Acute psychological stress: effects on chemotaxis and cellular adhesion molecule expression. Psychosom Med 65 (2003) 598-603
307. van der Poll T., Coyle S.M., Barbosa K., Braxton C.C., and Lowry S.F. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 97 (1996) 713-719
308. Szabo C., Hasko G., Zingarelli B., et al. Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia. Immunology 90 (1997) 95-100
309. Hasko G., Nemeth Z.H., Szabo C., Zsilla G., Salzman A.L., and Vizi E.S. Isoproterenol inhibits IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages. Brain Res Bull 45 (1998) 183-187
310. Elenkov I.J., Hasko G., Kovacs K.J., and Vizi E.S. Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by selective alpha- and beta-adrenergic drugs in mice. J Neuroimmunol 61 (1995) 123-131
311. Chou R.C., Stinson M.W., Noble B.K., and Spengler R.N. Beta-adrenergic receptor regulation of macrophage-derived tumor necrosis factor-alpha production from rats with experimental arthritis. J Neuroimmunol 67 (1996) 7-16
312. Hasko G., Szabo C., Nemeth Z.H., Salzman A.L., and Vizi E.S. Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice. J Neuroimmunol 88 (1998) 57-61
313. Ignatowski T.A., and Spengler R.N. Tumor necrosis factor-alpha: presynaptic sensitivity is modified after antidepressant drug administration. Brain Res 665 (1994) 293-299
314. Severn A., Rapson N.T., Hunter C.A., and Liew F.Y. Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J Immunol 148 (1992) 3441-3445
315. Gerard C., Bruyns C., Marchant A., et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177 (1993) 547-550
316. Suberville S., Bellocq A., Fouqueray B., et al. Regulation of interleukin-10 production by beta-adrenergic agonists. Eur J Immunol 26 (1996) 2601-2605
317. Panina-Bordignon P., Mazzeo D., Lucia P.D., et al. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest 100 (1997) 1513-1519
318. Fessler H.E., Otterbein L., Chung H.S., and Choi A.M. Alpha-2 adrenoceptor blockade protects rats against lipopolysaccharide. Am J Respir Crit Care Med 154 (1996) 1689-1693
319. Hayes M.A., Timmins A.C., Yau E.H., Palazzo M., Hinds C.J., and Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330 (1994) 1717-1722
320. Hensler T., Heidecke C., Hecker H., et al. Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production. J Immunol 161 (1998) 2655-2659
321. Lyte M. The role of catecholamines in gram-negative sepsis. Med Hypotheses 37 (1992) 255-258
322. Chiolero R., and Berger M. Endocrine response to brain injury. New Horiz 2 (1994) 432-442
323. Jarek M.J., Legare E.J., McDermott M.T., Merenich J.A., and Kollef M.H. Endocrine profiles for outcome prediction from the intensive care unit. Crit Care Med 21 (1993) 543-550
324. Rothwell P.M., and Lawler P.G. Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med 23 (1995) 78-83
325. Rothwell N.J., Luheshi G., and Toulmond S. Cytokines and their receptors in the central nervous system: physiology, pharmacology, and pathology. Pharmacol Ther 69 (1996) 85-95
326. O'Sullivan S.T., Lederer J.A., Horgan A.F., Chin D.H., Mannick J.A., and Rodrick M.L. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222 (1995) 482-490
327. Fabian T.C., Croce M.A., Fabian M.J., et al. Reduced tumor necrosis factor production in endotoxin-spiked whole blood after trauma: experimental results and clinical correlation. Surgery 118 (1995) 63-72
328. Brune I.B., Wilke W., Hensler T., Holzmann B., and Siewert Jr. Downregulation of T helper type 1 immune response and altered pro-inflammatory and anti-inflammatory T cell cytokine balance following conventional but not laparoscopic surgery. Am J Surg 177 (1999) 55-60
329. Woiciechowsky C., Asadullah K., Nestler D., et al. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med 4 (1998) 808-813
330. Prass K., Meisel C., Hoflich C., et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 198 (2003) 725-736
331. Plata-Salaman C.R. Brain injury and immunosuppression. Nat Med 4 (1998) 768-769
332. Wilder R.L. Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 13 (1995) 307-338
333. Elenkov I.J., Hoffman J., and Wilder R.L. Does differential neuroendocrine control of cytokine production govern the expression of autoimmune diseases in pregnancy and the postpartum period?. Mol Med Today 3 (1997) 379-383
334. Lorton D., Lubahn C., and Bellinger D.L. Potential use of drugs that target neural-immune pathways in the treatment of rheumatoid arthritis and other autoimmune diseases. Curr Drug Targets Inflamm Allergy 2 (2003) 1-30
335. Segal B.M., Dwyer B.K., and Shevach E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med 187 (1998) 537-546
336. Maini R.N., Elliott M.J., Charles P.J., and Feldmann M. Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus. Springer Semin Immunopathol 16 (1994) 327-336
337. Horwitz D.A., Gray J.D., Behrendsen S.C., et al. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum 41 (1998) 838-844
338. Arnason B.G., Noronha A.B., and Reder A.T. Immunoregulation in rapidly progressive multiple sclerosis. Ann NY Acad Sci 540 (1988) 4-12
339. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332 (1995) 1351-1362
340. Rogers M.P., and Fozdar M. Psychoneuroimmunology of autoimmune disorders. Adv Neuroimmunol 6 (1996) 169-177
341. Cohen W.R., Galen L.H., Vega-Rich M., and Young J.B. Cardiac sympathetic activity during rat pregnancy. Metabolism 37 (1988) 771-777
342. Magiakou M.A., Mastorakos G., Rabin D., et al. The maternal hypothalamic-pituitary-adrenal axis in the third trimester of human pregnancy. Clin Endocrinol Oxf 44 (1996) 419-428
343. Lin H., Mosmann T.R., Guilbert L., Tuntipopipat S., and Wegmann T.G. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 151 (1993) 4562-4573
344. Sacks G.P., Studena K., Sargent I.L., and Redman C.W.G. Normal pregnancy and preeclampsia both produc inflammatory changes in peripheral blood lekocytes akin to those of sepsis. Am J Obstet Gynecol 179 (1998) 80-86
345. Sacks G., Sargent I., and Redman C. An innate view of human pregnancy. Immunol Today 20 (1999) 114-118
346. Karaszewski J.W., Reder A.T., Maselli R., Brown M., and Arnason B.G. Sympathetic skin responses are decreased and lymphocyte beta-adrenergic receptors are increased in progressive multiple sclerosis. Ann Neurol 27 (1990) 366-372
347. Karaszewski J.W., Reder A.T., Anlar B., and Arnason G.W. Increased high affinity beta-adrenergic receptor densities and cyclic AMP responses of CD8 cells in multiple sclerosis. J Neuroimmunol 43 (1993) 1-7
348. Mackenzie F.J., Leonard J.P., and Cuzner M.L. Changes in lymphocyte beta-adrenergic receptor density and noradrenaline content of the spleen are early indicators of immune reactivity in acute experimental allergic encephalomyelitis in the Lewis rat. J Neuroimmunol 23 (1989) 93-100
349. Zoukos Y., Leonard J.P., Thomaides T., Thompson A.J., and Cuzner M.L. beta-Adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: a regulatory role for cortisol and interleukin-1. Ann Neurol 31 (1992) 657-662
350. Leonard J.P., Mackenzie F.J., Patel H.A., and Cuzner M.L. Hypothalamic noradrenergic pathways exert an influence on neuroendocrine and clinical status in experimental autoimmune encephalomyelitis. Brain Behav Immun 5 (1991) 328-338
351. Chelmicka-Schorr E., Kwasniewski M.N., Thomas B.E., and Arnason B.G. The beta-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol 25 (1989) 203-207
352. Wiegmann K., Muthyala S., Kim D.H., Arnason B.G., and Chelmicka-Schorr E. Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats. J Neuroimmunol 56 (1995) 201-206
353. Kuis W., de Jong-de Vos van Steenwijk C., Sinnema G., et al. The autonomic nervous system and the immune system in juvenile rheumatoid arthritis. Brain Behav Immun 10 (1996) 387-398
354. Leden I., Eriksson A., Lilja B., Sturfelt G., and Sundkvist G. Autonomic nerve function in rheumatoid arthritis of varying severity. Scand J Rheumatol 12 (1983) 166-170
355. Perry F., Heller P.H., Kamiya J., and Levine J.D. Altered autonomic function in patients with arthritis or with chronic myofascial pain. Pain 39 (1989) 77-84
356. Kalliomaki J.L., Saarimaa H.A., and Toivanen P. Axon reflex sweating in rheumatoid arthritis. Ann Rheum Dis 22 (1963) 46-49
357. Levine J.D., Collier D.H., Basbaum A.I., Moskowitz M.A., and Helms C.A. Hypothesis: the nervous system may contribute to the pathophysiology of rheumatoid arthritis. J Rheumatol 12 (1985) 406-411
358. Levine J.D., Dardick S.J., Roizen M.F., Helms C., and Basbaum A.I. Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci 6 (1986) 3423-3429
359. Levine J.D., Fye K., Heller P., Basbaum A.I., and Whiting-O'Keefe Q. Clinical response to regional intravenous guanethidine in patients with rheumatoid arthritis. J Rheumatol 13 (1986) 1040-1043
360. Levine J.D., Goetzl E., and Basbaum A. Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other polyarthritides. Rheum Dis Clin North Am 13 (1987) 369-383
361. Colpaert F.C., and van den Hoogen R.H. Time course of the ventilatory response to adjuvant arthritis in the rat. Life Sci 33 (1983) 1065-1073
362. Lorton D., Lubahn C., Klein N., Schaller J., and Bellinger D.L. Dual role for noradrenergic innervation of lymphoid tissue and arthritic joints in adjuvant-induced arthritis. Brain Behav Immun 13 (1999) 315-334
363. Levine J.D., Coderre T.J., Helms C., and Basbaum A.I. Beta 2-adrenergic mechanisms in experimental arthritis. Proc Natl Acad Sci USA 85 (1988) 4553-4556
364. Lorton D., Bellinger D., Duclos M., Felten S.Y., and Felten D.L. Application of 6-hydroxydopamine into the fatpads surrounding the draining lymph nodes exacerbates adjuvant-induced arthritis. J Neuroimmunol 64 (1996) 103-113
365. Lubahn C.L., Schaller J.A., Bellinger D.L., Sweeney S., and Lorton D. The importance of timing of adrenergic drug delivery in relation to the induction and onset of adjuvant-induced arthritis. Brain Behav Immun 18 (2004) 563-571
366. Coderre T.J., Basbaum A.I., Helms C., and Levine J.D. High-dose epinephrine acts at alpha 2-adrenoceptors to suppress experimental arthritis. Brain Res 544 (1991) 325328
367. 2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: Mechanisms of action. J Immunol 162 (1999) 6278-6283
368. Baerwald C., Graefe C., Muhl C., Von Wichert P., and Krause A. Beta 2-adrenergic receptors on peripheral blood mononuclear cells in patients with rheumatic diseases. Eur J Clin Invest 22 Suppl. 1 (1992) 42-46
369. Baerwald C., Graefe C., von Wichert P., and Krause A. Decreased density of beta-adrenergic receptors on peripheral blood mononuclear cells in patients with rheumatoid arthritis. J Rheumatol 19 (1992) 204-210
370. Baerwald C.G., Laufenberg M., Specht T., von Wichert P., Burmester G.R., and Krause A. Impaired sympathetic influence on the immune response in patients with rheumatoid arthritis due to lymphocyte subset-specific modulation of beta 2-adrenergic receptors. Br J Rheumatol 36 (1997) 1262-1269
371. Lombardi M.S., Kavelaars A., Schedlowski M., et al. Decreased expression and activity of G-protein-coupled receptors in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J 13 (1999) 715-725
372. Kuis W., and Heijnen C.J. Rheumatoid arthritis and juvenile chronic arthritis: the role of the neuro-endocrine system. Clin Exp Rheumatol 12 Suppl. 10 (1994) S29-S34
373. Heijnen C.J., Rouppe van der Voort C., Wulffraat N., van der Net J., Kuis W., and Kavelaars A. Functional alpha 1-adrenergic receptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis. J Neuroimmunol 71 (1996) 223-226
374. Lubahn C., Schaller J., and Lorton D. Chronic treatment with adrenergic agents attenuates the inflammation and bone destruction associated with adjuvant arthritis in the Lewis rat. Brain Behav Immun 15 (2001) 167
375. Rouppe van der Voort C., Kavelaars A., van de Pol M., and Heijnen C.J. Neuroendocrine mediators up-regulate alpha1b- and alpha1d-adrenergic receptor subtypes in human monocytes. J Neuroimmunol 95 (1999) 165-173
376. van der Poll T.J., Jansen E., Endert H.P., Sauerwein H.P., and van Deventer S.J.H. Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun 62 (1994) 2050-2946
377. Monastra G., and Secchi E.F. Beta-adrenergic receptors mediate in vivo the adrenaline inhibition of lipopolysaccharide-induced tumor necrosis factor release. Immunol Lett 38 (1993) 127-130
378. Ignatowski T.A., and Spengler R.N. Regulation of macrophage-derived tumor necrosis factor production by modification of adrenergic receptor sensitivity. J Neuroimmunol 61 (1995) 61-70
379. Lorton D., Lubahn C., Lindquist C.A., Schaller J., Washington C., and Bellinger D.L. Changes in the density and distribution of sympathetic nerves in spleens from Lewis rats with adjuvant-induced arthritis suggest that an injury and sprouting response occurs. J Comp Neurol 489 (2005) 260-273
380. Breneman S.M., Moynihan J.A., Grota L.J., Felten D.L., and Felten S.Y. Splenic norepinephrine is decreased in MRL-lpr/lpr mice. Brain Behav Immun 7 (1993) 135-143
381. Miller L.E., Justen H.P., Scholmerich J., and Straub R.H. The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. Fed Am Soc Exp Biol J 14 (2000) 2097-2107
382. Harle P., and Straub R.H. Neuroendocrine-immune aspects of accelerated aging in rheumatoid arthritis. Curr Rheumatol Rep 7 (2005) 389-394
383. Mapp P.I., Walsh D.A., Garrett N.E., et al. Effect of three animal models of inflammation on nerve fibres in the synovium. Ann Rheum Dis 53 (1994) 240-246
384. Green P.G., Miao F.J., Strausbaugh H., Heller P., Janig W., and Levine J.D. Endocrine and vagal controls of sympathetically dependent neurogenic inflammation. Ann NY Acad Sci 840 (1998) 282-288
385. Miao F.J., Janig W., and Levine J. Role of sympathetic postganglionic neurons in synovial plasma extravasation induced by bradykinin. J Neurophysiol 75 (1996) 715-724
386. Clark J.A., Inui T.S., Silliman R.A., et al. Patient's perception of quality of life after treatment for early prostate cancer. J Clin Oncol 21 (2003) 3777-3784
387. Visser A., van Andel G., Willems P., et al. Changes in health-related quality of life of men with prostate cancer 3 months after diagnosis: the role of psychosocial factors and comparison with benign prostate hyperplasia patients. Patient Educ Couns 49 (2003) 225-232
388. Cohen S., and Rabin B.S. Psychologic stress, immunity, and cancer: editorial; comment. J Natl Cancer Inst 90 (1998) 3-4
389. Turner-Cobb J.M., Sephton S.E., and Spiegel D. Psychosocial effects on immune function and disease progression in cancer: human studies. In: Ader R., Cohen N., and Felten D.L. (Eds). Psychoneuroimmunology. 3rd ed (2001), Academic Press, San Diego 565-582
390. King R. Edinburgh gate (1996), Addison Wesley Longman, Harlow, England
391. Shu S., Plautz G., Krauss J., and Chang A. Tumor immunology. J Am Med Assoc 278 (1997) 1972-1981
392. Herberman R. Natural killer cells: characteristic and possible role in resistance against tumor growth. In: Reif A.E., and Mitchel M.S. (Eds). Immunity to cancer (1985), Academic Press, San Diego
393. Trinchieri G. Biology of natural killer cells. Adv Immunol 47 (1989) 187-376
394. Whiteside T.L., and Herberman R.B. Role of human natural killer cells in immune surveillance of cancer. Curr Opin Immunol 7 (1994) 704-710
395. Karre K., Ljunggren H.G., Piontek G., and Kiesslinger R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 51 (1986) 675-678
396. Ljunggren H.G., and Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 11 (1990) 237-244
397. Raulet D.H., Correa I., Corral L., Dorfman J., and Wu M.F. Inhibitory effects of class I molecules on murine NK cells: speculations on function, specificity and self-tolerance. Semin Immunol 7 (1995) 103-107
398. Sanda M.G., Restifo N.P., Walsh J.C., et al. Molecular characterization of defective antigen processing in human prostate cancer. J Natl Cancer Inst 87 (1995) 280-285
399. Nasu Y., Bangma C.H., Hull G.W., et al. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model. Gene Ther 6 (1999) 338-349
400. Lee H.-M., Timme T.L., and Thompson T.C. Resistance to lysis by cytotoxic T cells: a dominant effect in metastatic mouse prostate cancer cells. Cancer Res 60 (2000) 1927-1933
401. Levy S.M., Herberman R.B., Lippman M., D'Angelo T., and Lee J. Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer. Behav Med 17 (1991) 67-75
402. Mantovani A., Bottazzi B., Colotta F., Sozanni S., and Ruco L. The origin and function of tumor-associated macrophages. Immunol Today 13 (1992) 265-270
403. Andersen B.L., Farrar W.B., Golden-Kreutz D., et al. Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst 90 (1998) 30-36
404. Baron R.S., Cutrona C.E., Hicklin D., Russell D.W., and Lubaroof D.M. Social support and immune function among spouses of cancer patients. J Pers Soc Psychol 59 (1990) 344-352
405. Glaser R., Kiecolt-Glaser J.K., Bonneau R.H., Malarkey W., Kennedy S., and Hughes J. Stress-induced modulation of the immune response to recombinant hepatitis B vaccine. Psychosom Med 54 (1992) 22-29
406. Linn B.S., Linn M.W., and Kilmas N.G. Effects of Psychosocial stress on surgical outcomes. Psychosom Med 50 (1988) 230-244
407. Snyder B.K., Roghmann K.J., and Sigal L.H. Stress and psychosocial factors: effects on primary cellular immune response. J Behav Med 16 (1993) 143-161
408. Theorell T., Orth-Gomer K., and Eneroth P. Slow-reacting immunoglobulin in relation to social support and changes in job strain: a preliminary note. Psychosom Med 52 (1990) 511-516
409. Thomas P.D., Goodwin J.M., and Goodwin J.S. Effect of social support on stress-related changes in cholesterol level, uric acid level, and immune function in an elderly sample. Am J Psychiatry 142 (1985) 735-737
410. Kiecolt-Glaser J.K., Dura J.R., Speicher C.E., Trask O.J., and Glaser R. Spousal caregivers of dementia victims: longitudinal changes in immunity and health. Psychosom Med 53 (1991) 345-362
411. Kiecolt-Glaser J.K., and Glaser R. Psychoneuroimmunology: can psychological interventions modulate immunity: special issue: behavioral medicine: an update for the 1990's. J Consult Clin Psychol 60 (1992) 569-575
412. Van Rood Y.R., Bogaards M., Goulmy E., and Houwelingen H.C. The effects of stress and relaxation on the in vitro immune response in man: a meta-analytic study. J Behav Med 16 (1993) 163-181
413. Bergsma J. Illness, the mind, and the body: cancer and immunology, an introduction. Theor Med 15 (1994) 337-347
414. Landmann R.M., Muller F.B., Perini C., Wesp M., Erne P., and Buhler F.R. Changes of immunoregulatory cells induced by psychological and physical stress: relationship to plasma catecholamines. Clin Exp Immunol 58 (1984) 127-135
415. Naliboff B.D., Benton D., Solomon G.F., et al. Immunological changes in young and old adults during brief laboratory stress. Psychosom Med 53 (1991) 121-132
416. Schedlowski M., Jacobs R., Stratmann G., et al. Changes of natural killer cells during acute psychological stress. J Clin Immunol 13 (1993) 119-126
417. Esterling B.A., Kiecolt-Glaser J.K., Bodnar J.C., and Glaser R. Chronic stress, social support and persistent alterations in the natural killer cell response to cytokines in older adults. Health Psychol 13 (1994) 291-298
418. Kiecolt-Glaser J.K., Ricker D., George J., et al. Urinary cortisol levels, cellular immunocompetency, and loneliness in psychiatric inpatients. Psychosom Med 46 (1984) 15-23
419. Kiecolt-Glaser J.K., Fisher L.D., Ogrocki P., Stout J.C., Speicher C.E., and Glaser R. Marital quality, marital disruption, and immune function. Psychosom Med 49 (1987) 13-34
420. Kiecolt-Glaser J.K., Glaser R., Shuttleworth E.C., Dyer C.S., Ogrocki P., and Speicher C.E. Chronic stress and immunity in family caregivers of Alzheimer's disease victims. Psychosom Med 49 (1987) 523-535
421. Kemeny M.E., Cohen F., Zegans L.S., and Conant M.A. Psychological and immunological predictors of genital herpes recurrence. Psychosom Med 52 (1989) 195-208
422. Stein M., Miller A.H., and Trestman R.L. Depression, the immune system, and health and illness. Findings in search of meaning. Arch Gen Psychiatry 48 (1991) 171-177
423. Ironson G., Lapierre A., Antoni M., et al. Changes in immune and psychological measures as a function of anticipation and reaction to news of HIV-1 antibody status. Psychosom Med 52 (1990) 247-270
424. Lechin F., van der Dijs B., Vitelli-Florez G., et al. Psychoneuroendocrinological and immunological parameters in cancer patients: involvement of stress and depression. Psychoneuroendocrinology 15 (1990) 435-451
425. Levy S.M. Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients. Psychosom Med 52 (1990) 73-85
426. Temoshok L., Heller B.W., Sagebiel R.W., et al. The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma. J Psychosom Res 29 (1985) 139-153
427. Shavit Y., Terman G.W., Martin F.C., Lewis J.W., Liebeskind J.C., and Gale R.P. Stress, opioid peptides, the immune system, and cancer. J Immunol 135 (1985) 834s-837s
428. Ben-Eliyahu S., Yirmiya R., Liebeskind J.C., Taylor A.N., and Gale R.P. Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system. Brain Behav Immun 5 (1991) 193-205
429. Hellstrand K., and Hermodsson S. An immunopharmacological analysis of adrenaline-induced suppression of human natural killer cell cytotoxicity. Int Arch Allergy Appl Immunol 89 (1989) 334-341
430. 2+-dependent pathways in the inhibition of human natural killer (NK) cell activity by cortisol. Immunopharmacology 18 (1989) 11-22
431. Benschop R.J., Nijkamp F.P., Ballieux R.E., and Heijnen C.J. The effects of beta-adrenoceptor stimulation on adhesion of human natural killer cells to cultured endothelium. Br J Pharmacol 113 (1994) 1311-1316
432. Benschop R.J., Rodriguez-Feuerhahn M., and Schedlowski M. Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain Behav Immun 10 (1996) 77-91
433. Schedlowski M., Hosch W., Oberbeck R., et al. Catecholamines modulate human NK cell circulation and function via spleen-independent beta 2-adrenergic mechanisms. J Immunol 156 (1996) 93-99
434. Dhabhar F.S., Miller A.H., McEwen B.S., and Spencer R.L. Effects of stress on immune cell distribution. Dynamics and hormonal mechanisms. J Immunol 154 (1995) 5511-5527
435. Romeo H.E., Colombo L.L., Esquifino A.I., Rosenstein R.E., Chuluyan H.E., and Cardinali D.P. Slower growth of tumours in sympathetically denervated murine skin. J Auton Nerv Syst 32 (1991) 159-164
436. ThyagaRajan S., Madden K.S., Kalvass J.C., Dimitrova S.S., Felten S.Y., and Felten D.L. l-deprenyl-induced increase in IL-2 and NK cell activity accompanies restoration of noradrenergic nerve fibers in the spleens of old F344 rats. J Neuroimmunol 92 (1998) 9-21
437. ThyagaRajan S., Felten S.Y., and Felten D.L. Restoration of sympathetic noradrenergic nerve fibers in the spleen by low doses of l-deprenyl treatment in young sympathectomized and old Fischer 344 rats. J Neuroimmunol 81 (1998) 144-157
438. Thyagarajan S., Meites J., and Quadri S.K. Deprenyl reinitiates estrous cycles, reduces serum prolactin, and decreases the incidence of mammary and pituitary tumors in old acyclic rats. Endocrinology 136 (1995) 1103-1110
439. Brenner G.J., Felten S.Y., Felten D.L., and Moynihan J.A. Sympathetic nervous system modulation of tumor matastases and host defense mechanisms. J Neuroimmunol 37 (1992) 191-201
440. Ben-Eliyahu S. Stress, natural killer cell activity, and tumor metastasis: the role of catecholamines and corticosteroids. In: Levi A., Grauer E., Ben-Nathan D., and De-Koet E.R. (Eds). New frontiers in stress research: modulation in brain function (1998), Harwood Academic, Amsterdam 203-215
441. Stefanski V., and Ben-Eliyahu S. Social confrontation and tumor metastasis in rats: defeat and beta-adrenergic mechanism. Physiol Behav 60 (1996) 277-282
442. Shakhar G., and Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J Immunol 160 (1998) 3251-3258
443. Ben-Eliyahu S., and Shakhar G. The impact of stress, catecholamines, and the menstrual cycle on NK activity and tumor development: from in vitro studies to biological significance. In: Ader R., Cohen N., and Felten D.L. (Eds). Psychoneuroimmunology. 3rd ed. vol. 2 (2001), Academic Press, San Diego 545-563
444. Hasegawa H., and Saiki I. Psychosocial stress augments tumor development through beta-adrenergic activation in mice. Jpn J Cancer Res 93 (2002) 729-735
445. Kyprianou N., and Benning C.M. Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis. Cancer Res 60 (2000) 4550-4555
446. Yang G., Timme T.L., Park S.H., Wu X., Wyllie M.G., and Thompson T.C. Transforming growth factor beta 1 transduced mouse prostate reconstitutions: II. Induction of apoptosis by doxazosin. Prostate 33 (1997) 157-163
447. Benning C.M., and Kyprianou N. Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action. Cancer Res 62 (2002) 597-602
448. Carmena M.J., Clemente C., Carrero I., Solano R.M., and Prieto J.C. G Proteins and β-adrenergic stimulation of adenylate cyclase activity in the diabetic rat prostate. Prostate 33 (1997) 46-54
449. Juarranz M.G., Guijarro L.G., Bajo A.M., Carmena M.J., and Prieto J.C. Ontogeny of vasoactive intestinal peptide receptors in rat ventral prostate. Gen Pharmacol 5 (1994) 509-514
450. Cox M.E., Deeble P.D., Lakhani S., and Parsons S.J. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression. Cancer Res 59 (1999) 3821-3830
451. Cox M.E., Deeble P.D., Bissonette E.A., and Parsons S.J. Activated 3′,5′-cyclic AMP dependent protein kinase is sufficient to induce neuroendocrine like differentiation of the LNCaP prostate tumor cell line. J Biol Chem 275 (2000) 13812-13818
452. Vizi E.S., Toth I.E., Orsó E., et al. Dopamine is taken up from the circulation by, and released from, local noradrenergic varicose axon terminals in zona glomerulosa of the rat: A neurochemical and immunocytochemical study. J Endocrinol 139 (1993) 213-226